Found: 8
Select item for more details and to access through your institution.
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38407-7
- By:
- Publication type:
- Article
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 5, p. 1189, doi. 10.1007/s00520-013-2071-5
- By:
- Publication type:
- Article
Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions.
- Published in:
- Head & Neck, 2019, v. 41, p. 6, doi. 10.1002/hed.25930
- By:
- Publication type:
- Article
Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2014, v. 87, n. 3, p. 159, doi. 10.1159/000362821
- By:
- Publication type:
- Article
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study.
- Published in:
- Oncologist, 2024, v. 29, n. 10, p. e1396, doi. 10.1093/oncolo/oyae109
- By:
- Publication type:
- Article
The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC.
- Published in:
- Oncogenesis, 2024, v. 13, n. 1, p. 1, doi. 10.1038/s41389-024-00532-3
- By:
- Publication type:
- Article